Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
Autoimmune Disorders01:29

Autoimmune Disorders

1.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

125
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gephyrin Neurological Autoimmunity.

Annals of neurology·2026
Same author

Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease.

Brain : a journal of neurology·2026
Same author

AEGIS reveals epitope- and clone-resolved convergence of CNS B and T cell autoreactivity in ROHHAD.

bioRxiv : the preprint server for biology·2026
Same author

Long-Term Outcomes in Stiff Person Spectrum Disorder.

European journal of neurology·2026
Same author

Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders.

Journal of immunological methods·2026
Same author

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice.

Annals of clinical and translational neurology·2026

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.4K

Autoimmune encephalitis management: MS centers and beyond.

Andrew McKeon1, Anastasia Zekeridou1

  • 1Departments of Laboratory Medicine and Pathology, and Neurology, Mayo Clinic, Rochester, MN, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 14, 2020
PubMed
Summary

The management of autoimmune encephalitis is shifting. As incidence rises, neurologists in various specialties, not just multiple sclerosis (MS) experts, need expertise in diagnosing and treating these complex CNS disorders.

Keywords:
Autoimmune encephalitismultiple sclerosis

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

5.4K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.4K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Disorders
  • Autoimmune Neurology

Background:

  • Multiple sclerosis (MS) specialists traditionally manage certain autoimmune CNS disorders.
  • Increasing incidence of autoimmune encephalitis, due to improved recognition, necessitates a broader management approach.
  • Patients with autoimmune encephalitis are initially seen in hospitals, general neurology, and subspecialty clinics like epilepsy.

Purpose of the Study:

  • To address the question of who should manage the growing number of autoimmune encephalitis cases.
  • To highlight the evolving role of various neurology subspecialties in managing autoimmune encephalitis.
  • To emphasize the need for broader expertise in autoimmune encephalitis care beyond MS specialists.

Main Methods:

  • Review of current practices in managing non-demyelinating inflammatory and autoimmune CNS disorders.
  • Analysis of the training and expertise of neurologists in autoimmune neurology and related subspecialties.
  • Discussion of the clinical pathways for patients with autoimmune encephalitis.

Main Results:

  • Autoimmune neurology is emerging as a specialty focused on disorders like autoimmune encephalitis.
  • Neurologists with training in MS, hospital neurology, movement disorders, and epilepsy are increasingly involved.
  • There is a growing need for general and subspecialty neurology providers to be proficient in autoimmune encephalitis management.

Conclusions:

  • The management of autoimmune encephalitis requires a multidisciplinary approach involving various neurology subspecialties.
  • Enhanced training in autoimmune neurology is crucial for neurologists to effectively manage these complex CNS conditions.
  • Improved recognition and management strategies are essential to address the rising incidence of autoimmune encephalitis.